In group 3, the membrane was lysed within 4 24 hours after t PA injection in all cases, and no hyphema occurred.
第3组患者,4~24小时内瞳孔区的纤维蛋白膜全部吸收,无前房内出血。
Objective To assess the clinical significance of plasma t-PA, PAI-1 in acute cerebral infarction.
目的探讨血浆组织型纤溶酶原激活物(t -PA)及其抑制物(PAI - 1)在急性脑梗死发病中的意义。
The study compared the efficacy and safety of ultrasound with t-PA vs t-PA only in a trial involving 126 patients.
该研究比较了联合应用超声波和t -PA与单独使用t - PA的作用与安全性,研究涉及了126例患者。
Therefore, t-PA is considered as a more effective and safer thrombolytic agent.
故t-PA是一种效果较好、治疗剂量时较为安全的溶栓剂。
The thrombolytic effect was compared between urokinase (UK) and human tissue plasminogen activator (t-PA) in rabbits with experimental iliofemoral artery thrombus.
本文用尿激酶(UK)和人体组织型纤溶酶原激活剂(t - PA)进行了兔髂股动脉血栓实验性溶解的对照研究。
The morphology had relationship with t-PA production.
菌体形态和t-PA的产生密切相关。
Objective To investigate effects of fibrinolytic system upon deep venous thrombosis, focused on PLG, t-PA and PAI-1.
目的以纤溶酶原、t - PA和PAI - 1为轴心,探讨纤溶系统对深静脉血栓形成(DVT)的影响。
Results: The activity of PAI-1 was higher and t-PA was lower in patients with coronary heart disease, and this difference is also found between Type a and Non Type a patients.
结果:冠心病患者比正常人群的PAI - 1活性上升,t -PA活性下降;这种改变在不同行为类型之间比较,A型行为类型比非a型行为类型的冠心病患者PAI - 1的活性升高而t - PA活性降低。
The purified t-PA has a higher affinity for fibrin than urokinase. In addition, the melanoma plasminogen activator appeared to be immunologically different from urokinase.
纯化的t-PA与尿激酶相比较,发现前者有更高亲和纤维蛋白的能力。
According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly, or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).
据报道,纳豆激酶有和胞浆素一样的可直接分解纤维蛋白的生物特性,或者增强尿激酶原和t—PA(人组织型纤溶酶原激活剂)的活性。
According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly, or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).
据报道,纳豆激酶有和胞浆素一样的可直接分解纤维蛋白的生物特性,或者增强尿激酶原和t—PA(人组织型纤溶酶原激活剂)的活性。
应用推荐